Standout Papers

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves 2013 2026 2017 2021 917
  1. Dabigatran versus Warfarin in Patients with Mechanical Heart Valves (2013)
    John W. Eikelboom, Stuart J. Connolly et al. New England Journal of Medicine
  2. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (2017)
    Christopher P. Cannon, Deepak L. Bhatt et al. New England Journal of Medicine

Immediate Impact

2 from Science/Nature 69 standout
Sub-graph 1 of 18

Citing Papers

Cardiac Rehabilitation — Challenges, Advances, and the Road Ahead
2024 Standout
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation
2023 Standout
2 intermediate papers

Works of Ruth Harper being referenced

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
2013 Standout
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)
2012
and 1 more

Author Peers

Author Last Decade Papers Cites
Ruth Harper 1866 151 743 346 16 2.1k
Yasser Khder 1536 78 557 215 24 1.7k
F.R. Rosendaal 2064 83 880 383 21 2.6k
Yazan Daaboul 1391 105 617 445 49 1.9k
Paul A. Reilly 1232 175 855 232 28 1.9k
Gianluigi Devoto 978 211 661 304 12 1.5k
Martina Brueckmann 2296 97 1019 203 42 2.5k
Jaapjan D. Snoep 1157 180 482 629 20 1.6k
Ernesto Paolasso 1507 183 323 459 19 1.9k
Alex Gold 1096 176 919 468 42 1.9k
HR Büller 530 327 921 407 18 1.6k

All Works

Loading papers...

Rankless by CCL
2026